+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-09-08Number of Pages: 154

Radiodermatitis Market (Product type - Topical (Corticosteroids, Hydrophilic Creams, and Topical Antibiotics), Oral Medication (Corticosteroids, Oral Analgesics, Antibiotics), and Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing (GM-CSF Gauze and Silver Leaf Dressing); By Distribution Channel - Hospital Pharmacy, Retail Pharmacy Store, and Online Store) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Global Radiodermatitis Market: Snapshot

The global radiodermatitis market has been witnessing a significant progress over the last few years on the grounds of the rising prevalence of cancer and the growing uptake of radiation therapy for its treatment. Thanks to the increasing focus on product innovations and advancements in existing products, the market is also showing high potential for future growth.

Over the coming years, the unmet medical needs of consumers in emerging regions is expected to open a plethora of growth opportunities for market players, leading to a substantial rise in this market. Expanding at a CAGR of 3.90% over the period from 2016 to 2024, the market, which stood at US$299.6 mn in 2015, is anticipated to increase to US$421.5 mn by the end of the forecast period.

radiodermatitis-market

 

Asia Pacific to Retain Leadership in Global Radiodermatitis Market

Spread across Asia Pacific, the Middle East and Africa, North America, Latin America, and Europe, the market for radiodermatitis boasts of a robust presence across the world. Asia Pacific, among all, has been leading the global radiodermatitis market, thanks to a higher percentage of patients eligible for radiotherapy. The increasing pool of cancer patients is expected to drive the Asia Pacific radiodermatitis market further, ensuring its dominance over the next few years. Since a number of Asian economies, situated in the tropical region, have humid weather conditions, the severity of radiation dermatitis is significantly high in this geographical segment, which is also expected to boost the market for radiodermatitis in Asia Pacific in the near future.

Amongst other regional markets for radiodermatitis, Europe also possesses a considerable share in the global market on account of the increase in research and development activities in life sciences, upswing in academic research in radiation dermatitis, and the escalating number of product launches in this region. The market in North America has been driven by the presence of a large pool of well-established pharmaceutical enterprises, research organizations, and several government institutes, which actively work on developing a standard treatment solution for radiodermatitis.

Latin America and the Middle East and Africa are likely to gain considerably from the increasing attention of multinational companies on them. The large base of the unprivileged population, particularly in the Middle East and central Africa, and the implementation of new policies encouraging the uptake of radiotherapy in these regions are anticipated to boost the radiodermatitis markets in Latin America and the Middle East and Africa.

Topical Agents to Continue Being Most Valued Radiodermatitis Products

Topical, oral medication, and dressings are the main products available in the global market for radiodermatitis. Topical agents witness a higher demand from end users than other radiodermatitis products and are anticipated to continue doing so over the next few years. The ease of availability and cost benefits of topical products have fueled their demand among all strata of consumers, which is likely to reflect positively on their sales in the near future.

Corticosteroid creams, hydrophilic creams, and topical antibiotics are most preferred topical products across the world. Hydrophilic creams report a much higher demand than the other two. Analysts expect this scenario to remain so over the years to come.

Stratpharma AG, Smith & Nephew Plc, Molnlycke Health Care, Intermed Pharmaceuticals, Derma Sciences Inc., ConvaTec Inc., BMG Pharma S.r.l., Acelity LP Inc., and 3M are the key participants in the global Radiodermatitis market.

Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Chapter 2. Assumptions and Research Methodology

Chapter 3. Executive Summary: Global Radiodermatitis Market

Chapter 4. Market Overview
4.1. Introduction
4.2. Market Dynamics
      4.2.1. Drivers
      4.2.2. Restraints
      4.2.3. Opportunity
4.3. Value Chain Analysis

Chapter 5. Global Radiodermatitis Market Analysis and Forecast, by Product
5.1. Key Findings
5.2. Introduction
5.3. Market Size (US$ Mn) Forecast, by Product
      5.3.1. Topical
               5.3.1.1. Corticosteroids
               5.3.1.2. Hydrophilic Creams
               5.3.1.3. Others (topical antibiotics)
      5.3.2. Oral Medication
               5.3.2.1. Corticosteroids
               5.3.2.2. Others (analgesics, antibiotics, etc.)
      5.3.3. Dressings
               5.3.3.1. Hydrogel
               5.3.3.2. Hydrocolloid
               5.3.3.3. No Sting Barrier Film
               5.3.3.4. Honey Impregnated Gauze
               5.3.3.5. Silicone Coated Dressing
               5.3.3.6. Others (silver leaf dressings, GM-CSF gauze, etc.)
5.4. Market Attractiveness Analysis, by Product, 2015
5.5. Key Trends

Chapter 6. Global Radiodermatitis Market Analysis and Forecast, by Distribution Channel
6.1. Key Findings
6.2. Introduction
6.3. Market Size (US$ Mn) Forecast, by Distribution Channel
      6.3.1. Hospital Pharmacy
      6.3.2. Retail Pharmacy Store 
      6.3.3. Online Store
6.4. Market Attractiveness Analysis, by Distribution Channel, 2015

Chapter 7. Pipeline Analysis
7.1. List of discontinued trials
7.2. Clinical trial data for open studies

Chapter 8. Global Radiodermatitis Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Introduction
8.3. Market Size (US$ Mn) Forecast, by Region
      8.3.1. North America
      8.3.2. Europe
      8.3.3. Asia Pacific
      8.3.4. Latin America
      8.3.5. Middle East & Africa
8.4. Market Attractiveness Analysis, by Region, 2015
8.5. Key Trends

Chapter 9. North America Radiodermatitis Market Analysis and Forecast
9.1. Key Findings
9.2. Introduction
9.3. Market Size (US$ Mn) Forecast, by Product 
      9.3.1. Topical
      9.3.2. Oral Medication
      9.3.3. Dressings
9.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      9.4.1. Hospital Pharmacy
      9.4.2. Retail Pharmacy Store
      9.4.3. Online Store
9.5. Market Size (US$ Mn) Forecast, by Country
      9.5.1. U.S.
      9.5.2. Canada
9.6. Market Attractiveness Analysis, by Product, 2015
9.7. Market Attractiveness Analysis, by Distribution Channel, 2015
9.8. Key Trends

Chapter 10. Europe Radiodermatitis Market Analysis and Forecast
10.1. Key Findings
10.2. Introduction
10.3. Market Size (US$ Mn) Forecast, by Product 
      10.3.1. Topical
      10.3.2. Oral Medication
      10.3.3. Dressings
10.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      10.4.1. Hospital Pharmacy
      10.4.2. Retail Pharmacy Store
      10.4.3. Online Store
10.5. Market Size (US$ Mn) Forecast, by Country
      10.5.1. U.K.
      10.5.2. Germany
      10.5.3. Rest of Europe
10.6. Market Attractiveness Analysis, by Product, 2015 
10.7. Market Attractiveness Analysis, by Distribution Channel, 2015
10.8. Key Trends

Chapter 11. Asia Pacific Radiodermatitis Market Analysis and Forecast
11.1. Key Findings
11.2. Introduction
11.3. Market Size (US$ Mn) Forecast, by Product 
      11.3.1. Topical
      11.3.2. Oral Medication
      11.3.3. Dressings
11.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      11.4.1. Hospital Pharmacy
      11.4.2. Retail Pharmacy Store
      11.4.3. Online Store
11.5. Market Size (US$ Mn) Forecast, by Country
      11.5.1. China
      11.5.2. Japan
      11.5.3. Rest of Asia Pacific
11.6. Market Attractiveness Analysis, by Product, 2015 
11.7. Market Attractiveness Analysis, by Distribution Channel, 2015
11.8. Key Trends

Chapter 12. Latin America Radiodermatitis Market Analysis and Forecast
12.1. Key Findings
12.2. Introduction
12.3. Market Size (US$ Mn) Forecast, by Product 
      12.3.1. Topical
      12.3.2. Oral Medication
      12.3.3. Dressings
12.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      12.4.1. Hospital Pharmacy
      12.4.2. Retail Pharmacy Store
      12.4.3. Online Store
12.5. Market Size (US$ Mn) Forecast, by Country
      12.5.1. Brazil
      12.5.2. Mexico
      12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis, by Product, 2015 
12.7. Market Attractiveness Analysis, by Distribution Channel, 2015
12.8. Key Trends

Chapter 13. Middle East & Africa Radiodermatitis Market Analysis and Forecast
13.1. Key Findings
13.2. Introduction
13.3. Market Size (US$ Mn) Forecast, by Product 
      13.3.1. Topical
      13.3.2. Oral Medication
      13.3.3. Dressings
13.4. Market Size (US$ Mn) Forecast, by Distribution Channel
      13.4.1. Hospital Pharmacy
      13.4.2. Retail Pharmacy Store
      13.4.3. Online Store
13.5. Market Size (US$ Mn) Forecast, by Country
      13.5.1. UAE
      13.5.2. South Africa
      13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis, by Product, 2015 
13.7. Market Attractiveness Analysis, by Distribution Channel, 2015
13.8. Key Trends

Chapter 14. Competition Landscape
14.1. Market Share Analysis
14.2. Competition Matrix
14.3. Company Profiles
      14.3.1. 3M 
               14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
               14.3.1.2. Financial Overview
               14.3.1.3. Product Portfolio
               14.3.1.4. SWOT Analysis
               14.3.1.5. Strategic Overview
      14.3.2. Acelity LP, Inc.
               14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
               14.3.2.2. Financial Overview
               14.3.2.3. Product Portfolio
               14.3.2.4. SWOT Analysis
               14.3.2.5. Strategic Overview
      14.3.3. BMG Pharma S.r.l.
               14.3.3.1. Company Overview (HQ, business segments, employee strength)
               14.3.3.2. Product Portfolio
               14.3.3.3. SWOT Analysis
               14.3.3.4. Recent Developments
               14.3.3.5. Strategic Overview
      14.3.4. ConvaTec, Inc.
               14.3.4.1. Company Overview (HQ, business segments, employee strength)
               14.3.4.2. Financial Overview
               14.3.4.3. Product Portfolio
               14.3.4.4. SWOT Analysis
               14.3.4.5. Strategic Overview
      14.3.5. Derma Sciences Inc.
               14.3.5.1. Company Overview (HQ, business segments, employee strength)
               14.3.5.2. Financial Overview
               14.3.5.3. Product Portfolio
               14.3.5.4. SWOT Analysis
               14.3.5.5. Strategic Overview
      14.3.6. Intermed Pharmaceuticals
               14.3.6.1. Company Overview (HQ, business segments, employee strength)
               14.3.6.2. Product Portfolio
               14.3.6.3. SWOT Analysis
               14.3.6.4. Recent Developments
               14.3.6.5. Strategic Overview
      14.3.7. Molnlycke Health Care
               14.3.7.1. Company Overview (HQ, business segments, employee strength)
               14.3.7.2. Financial Overview
               14.3.7.3. Product Portfolio
               14.3.7.4. SWOT Analysis
               14.3.7.5. Strategic Overview
      14.3.8. Smith & Nephew plc
               14.3.8.1. Company Overview (HQ, business segments, employee strength)
               14.3.8.2. Financial Overview
               14.3.8.3. Product Portfolio
               14.3.8.4. SWOT Analysis
               14.3.8.5. Strategic Overview
      14.3.9. Stratpharma AG
               14.3.9.1. Company Overview (HQ, business segments, employee strength)
               14.3.9.2. Product Portfolio
               14.3.9.3. SWOT Analysis
               14.3.9.4. Strategic Overview
               14.3.9.5. Value Chain
      14.3.10. Others

List of Figures

Figure 1: Global Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 2: Global Radiodermatitis Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 3: Global Topical Products Market Revenue (US$ Mn), 2014–2024
Figure 4: Global Oral Medication Market Revenue (US$ Mn), 2014–2024
Figure 5: Global Dressings Market Revenue (US$ Mn), 2014–2024
Figure 6: Global Topical Corticosteroids Market Revenue (US$ Mn), 2014–2024
Figure 7: Global Hydrophilic Creams Market Revenue (US$ Mn), 2014–2024
Figure 8: Global Other Topical agents Market Revenue (US$ Mn), 2014–2024
Figure 9: Global Oral Analgesic, Anti-inflammatory & Antibiotic Market Revenue (US$ Mn), 2014-2024
Figure 10: Global Oral Corticosteroids Market Revenue (US$ Mn), 2014–2024
Figure 11: Global Hydrogel Market Revenue (US$ Mn), 2014–2024
Figure 12: Global Hydrocolloid Market Revenue (US$ Mn), 2014–2024
Figure 13: Global No Sting Barrier Film Market Revenue (US$ Mn), 2014–2024
Figure 14: Global Honey Impregnated Gauze Market Revenue (US$ Mn), 2014–2024
Figure 15: Global Silicone Coated Dressing Market Revenue (US$ Mn), 2014–2024
Figure 16: Global Other Dressings Market Revenue (US$ Mn), 2014–2024
Figure 17: Radiodermatitis Market Attractiveness Analysis, by Product Type
Figure 18: Global Radiodermatitis Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 19: Global Hospital Pharmacy Market Revenue (US$ Mn), 2014–2024
Figure 20: Global Retail Pharmacy Store Market Revenue (US$ Mn), 2014–2024
Figure 21: Global Online Store Market Revenue (US$ Mn), 2014–2024
Figure 22: Radiodermatitis Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 23: Global Radiodermatitis Market Value Share Analysis, by Region, 2015 and 2024
Figure 24: Radiodermatitis Market Attractiveness Analysis, by Region, 2015
Figure 25: North America Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 26: North America Market Attractiveness Analysis, by Country, 2015
Figure 27: North America Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 28: North America Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 29: North America Market Value Share Analysis, by Country, 2015 and 2024
Figure 30: North America Market Attractiveness Analysis, by Product Type, 2015
Figure 31: North America Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 32: Europe Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 33: Europe Market Attractiveness Analysis, by Country, 2015
Figure 34: Europe Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 35: Europe Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 36: Europe Market Value Share Analysis, by Country, 2015 and 2024
Figure 37: Europe Market Attractiveness Analysis, by Product Type, 2015
Figure 38: Europe Market Attractiveness Analysis, by Distribution Channel, 2015 
Figure 39: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 40: Asia Pacific Market Attractiveness Analysis, by Country, 2015
Figure 41: Asia Pacific Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 42: Asia Pacific Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 43: Asia Pacific Market Value Share Analysis, by Country, 2015 and 2024
Figure 44: Asia Pacific Market Attractiveness Analysis, by Product Type, 2015
Figure 45: Asia Pacific Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 46: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 47: Latin America Market Attractiveness Analysis, by Country, 2015
Figure 48: Latin America Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 49: Latin America Market Value Share Analysis, by Distribution Channel, 2015 and 2024
Figure 50: Latin America Market Value Share Analysis, by Country, 2015 and 2024
Figure 51: Latin America Market Attractiveness Analysis, by Product Type, 2015
Figure 52: Latin America Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 53: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, 2016–2024
Figure 54: Middle East & Africa Market Attractiveness Analysis, by Country, 2015
Figure 55: Middle East & Africa Market Value Share Analysis, by Product Type, 2015 and 2024
Figure 56: Middle East & Africa Market Value Share Analysis by Distribution Channel, 2015 and 2024
Figure 57: Middle East & Africa Market Value Share Analysis, by Country, 2015 and 2024
Figure 58: Middle East & Africa Market Attractiveness Analysis, by Product Type, 2015
Figure 59: Middle East & Africa Market Attractiveness Analysis, by Distribution Channel, 2015
Figure 60: Global Radiodermatitis Market Share Analysis by Company (2015)

List of Tables

Table 1: Global Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 2: Global Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 3: List of Discontinued Clinical Trials
Table 4: List of Open Clinical Trials
Table 5: Global Radiodermatitis Market Size (US$ Mn) Forecast, by Region, 2016–2024
Table 6: North America Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 7: North America Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 8: North America Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 9: Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 10: Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 11: Europe Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 12: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 13: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 14: Asia Pacific Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 15: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 16: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 17: Latin America Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024
Table 18: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Product Type, 2014–2024
Table 19: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2024
Table 20: Middle East & Africa Radiodermatitis Market Size (US$ Mn) Forecast, by Country, 2016–2024

Global Radiodermatitis Market: Overview

Radiodermatitis, also known as radiation dermatitis, is a peculiar symptom caused as a result of radiation therapy pertaining to the treatment of cancerous as well as noncancerous conditions, and has significant negative impact on a patient’s physical functionalities and quality of life. It has been estimated that in developed countries such as the U.S., Canada, Australia, the U.K, France, and Germany, nearly half of the patients who receive treatment for cancer was also subjected to radiation therapy during the illness, and about all of them experience some degree of skin reaction. As the cases of cancer escalates across the world, the demand in the global radiodermatitis is expected to increment at a considerable CAGR of 3.90% during the forecast period of 2016 to 2024. 

This report on the global radiodermatitis market estimates the valuation of the market to swell up to US$421.5 mn by the end of 2024, increasing from its evaluated worth of US$299.6 mn in 2015. This report, developed by a group of professional market research analysts, aspires to serve as a credible business tool for the stakeholders of this market. The report studies the prospects of various segments of the market, based on product, distribution channel, and geography, as well as profiles a number of leading players to understand the competitive landscape. Qualitative and quantitative assessment of all factors that may influence the demand for radiodermatitis has been provided in the report. 

Global Radiodermatitis Market: Trends & Opportunities

According to the International Agency for Research on Cancer (IARC), there were 14.1 million new cases of cancer across the world, and the figure is estimated to reach up to 21.7 million by the end of 2030. This substantial patient volume is the primary driver of the global radiodermatitis market. In addition to that, increasing focus on product innovation as well as advancements in the existing products are also expected to favor the market in the near future. Growing number of private and public healthcare organizations, who are constantly trying to promote the awareness regarding radiodermatitis treatment and management, and rising number of clinical studies to evaluate the efficiency of radiodermatitis treatment are some of the other factors favoring the global radiodermatitis market. 

Based on product, the global radiodermatitis market has been segmented into topical, oral medication, and dressings. While topical segment is sub-segmented into hydrophilic creams, corticosteroids, and others such as antibiotics, oral medical is further divided into corticosteroids and others such as antibiotics and oral analgesics, whereas dressing segment is further categorized into hydrogel, no sting barrier film, hydrocolloid, honey impregnated gauze, silicone coated dressing, and others such as silver leaf dressing and GM-CSF gauze. On the basis of dressing channel, the market has been bifurcated into hospital pharmacy, online store, and retail pharmacy store.

Global Radiodermatitis Market: Regional Outlook

Though the demand for radiodermatitis is growing in all regions across the globe, Asia Pacific currently serves the maximum demand, owing to higher percentage untapped patient-base. A number of emerging economies in the Asian region are situated in tropical region with humid weather conditions, in which the effect of radiation dermatitis is quite high. Extensive collaborations among the key players in order to increase their product portfolio and involvement of well-established pharmaceutical companies in this region on commercialization of their products are also expected to help them increment their shares in this region. 

Companies mentioned in the research report

The report detects Smith & Nephew plc, 3M Healthcare, Acelity, Convatec, Inc., and Molnlycke Health Care as the leading companies in the global radiodermatitis market, collectively accounting for 47% of the shares in 2015. 

Key Segments of the Global Radiodermatitis Market

Global Radiodermatitis Market, by Product

  • Topical
    • Corticosteroids
    • Hydrophilic Creams
    • Others (topical antibiotics)
  • Oral Medication
    • Corticosteroids
    • Other (oral analgesics, antibiotics, etc.)
  • Dressings
    • Hydrogel
    • Hydrocolloid
    • No Sting Barrier Film
    • Honey Impregnated Gauze
    • Silicone Coated Dressing
    • Others (GM-CSF gauze, silver leaf dressing, etc.)

Global Radiodermatitis Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy Store
  • Online Store

Global Radiodermatitis Market, by Geography

  • North America
    • U.S.
    • Canada
  • Asia Pacific
    • China
    • Japan
    • Rest of APAC
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • UAE
    • South Africa
    • Rest of Middle East & Africa 

Major regions analyzed under this research report are:

  • Europe
  • North America
  • Asia Pacific
  • Rest of the World 

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years 

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top